Solu Therapeutics, a company developing a new type of antibody drug, unveiled $41 million in financing on Wednesday for clinical testing of a therapy with the potential to bring a safer and more ...
BOSTON, Dec. 9, 2024 /PRNewswire/ -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today ...
Solu is a computer that wants to rethink how users interact with their computer. It's described as an advanced cloud-linked computer that takes the worry of storage space, file backups, and software ...
Another hardware startup is sparking up in Finland. Helsinki-based startup Solu has taken in a $1.3 million seed round, ahead of a planned product launch this fall. The stealthy startup has not yet ...
BOSTON--(BUSINESS WIRE)--Solu Therapeutics, a precision-medicine company developing therapeutics to eliminate disease-driving cells, today announced the appointment of Philip J. Vickers, Ph.D., as ...
Funding to support clinical evaluation of STX-0712, drive additional pipeline programs, and target new applications of company's proprietary CyTAC™ and TicTAC™ platforms. Phase 1 trial of STX-0712 to ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Riddhi Kanetkar Every time Riddhi publishes a story, you’ll get an alert straight to your inbox ...
BOSTON--(BUSINESS WIRE)--Solu Therapeutics, a precision-medicine company developing therapeutics to eliminate disease-driving cells, founded by Longwood Fund, today announced the closing of an ...
Solu Machines is introducing a one-of-a-kind type of computer, dubbed Solu, via a Kickstarter campaign. Solu is a touchscreen, cloud-connected mini PC, measuring only 4.5 inches square which users can ...
Solutions Group, Inc., through its subsidiaries, develops and sells advanced transportation and automotive safety technology products in the United States. The company’s products include Idrive X1, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results